In a mouse model of psoriasis induced by topical application of Imiquimod, it was found that ILC3s are a cellular source of IL-17A and IL-22 that mediate the Imiquimod-induced psoriasis-like disease (Pantelyushin et al., 2012). The gene discussed is IL17A; the disease is psoriasis.